AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
Aerosonic Corp. (NYSE: AIM) Delayed: 0.23 --0 (-0%)
Previous Close $0.23    52 Week High $8.92 
Open $0.23    52 Week Low $2.64 
Day High $0.24    P/E 0.37 
Day Low $0.23    EPS $0.62 
Volume 9,319,423